NM_001018113.3:c.1349G>A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_001018113.3(FANCB):​c.1349G>A​(p.Cys450Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,158,709 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000019 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000016 ( 0 hom. 8 hem. )

Consequence

FANCB
NM_001018113.3 missense

Scores

4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.29

Publications

0 publications found
Variant links:
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
FANCB Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • VACTERL association, X-linked, with or without hydrocephalus
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • VACTERL with hydrocephalus
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant X-14850652-C-T is Benign according to our data. Variant chrX-14850652-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 456176.
BS2
High Hemizygotes in GnomAdExome4 at 8 AR,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCBNM_001018113.3 linkc.1349G>A p.Cys450Tyr missense_variant Exon 7 of 10 ENST00000650831.1 NP_001018123.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCBENST00000650831.1 linkc.1349G>A p.Cys450Tyr missense_variant Exon 7 of 10 NM_001018113.3 ENSP00000498215.1

Frequencies

GnomAD3 genomes
AF:
0.0000187
AC:
2
AN:
107008
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000101
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000703
GnomAD2 exomes
AF:
0.0000227
AC:
4
AN:
175901
AF XY:
0.0000652
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000385
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000162
AC:
17
AN:
1051701
Hom.:
0
Cov.:
25
AF XY:
0.0000247
AC XY:
8
AN XY:
323617
show subpopulations
African (AFR)
AF:
0.0000392
AC:
1
AN:
25489
American (AMR)
AF:
0.00
AC:
0
AN:
34723
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18935
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29737
South Asian (SAS)
AF:
0.0000192
AC:
1
AN:
51973
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40155
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3966
European-Non Finnish (NFE)
AF:
0.0000175
AC:
14
AN:
802266
Other (OTH)
AF:
0.0000225
AC:
1
AN:
44457
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.414
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000187
AC:
2
AN:
107008
Hom.:
0
Cov.:
22
AF XY:
0.0000332
AC XY:
1
AN XY:
30116
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
28804
American (AMR)
AF:
0.000101
AC:
1
AN:
9885
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2606
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3452
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2502
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5242
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
227
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52192
Other (OTH)
AF:
0.000703
AC:
1
AN:
1423
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000959
Hom.:
1
Bravo
AF:
0.0000264
ExAC
AF:
0.0000495
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Fanconi anemia Benign:2
Oct 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2022
Sema4, Sema4
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Inborn genetic diseases Uncertain:1
May 25, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1349G>A (p.C450Y) alteration is located in exon 7 (coding exon 5) of the FANCB gene. This alteration results from a G to A substitution at nucleotide position 1349, causing the cysteine (C) at amino acid position 450 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
14
DANN
Benign
0.94
DEOGEN2
Benign
0.26
T;T;T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.61
T;.;T
M_CAP
Benign
0.022
T
MetaRNN
Uncertain
0.45
T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Uncertain
2.5
M;M;.
PhyloP100
2.3
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-4.1
D;D;D
REVEL
Benign
0.25
Sift
Benign
0.45
T;T;T
Sift4G
Benign
0.52
T;T;T
Polyphen
0.96
P;P;.
Vest4
0.34
MutPred
0.68
Loss of disorder (P = 0.0986);Loss of disorder (P = 0.0986);Loss of disorder (P = 0.0986);
MVP
0.44
MPC
0.57
ClinPred
0.30
T
GERP RS
4.7
Varity_R
0.29
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs764817410; hg19: chrX-14868774; API